New research elucidates the mechanisms behind acrodysostosis type 1, focusing on how PRKAR1A mutations disrupt cAMP-PKA signaling pathways. This study enhances understanding of the disease's molecular underpinnings.
acrodysostosis type 1 mechanisms explaining prkar1a mutation mediated dysregulation of camp pka signalling
Original title: “Acrodysostosis type 1: mechanisms explaining PRKAR1A mutation mediated dysregulation of cAMP-PKA signalling.”